BRIEF published on 08/05/2025 at 09:58, 9 months 8 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:55, 9 months 8 days ago SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance SCHOTT Pharma reports Q3 2025 revenues up 3% yoy at EUR 256m and gives FY 2025 guidance with EBITDA expected to be around 28.0%. Full financial results to be published on August 12, 2025 Revenues EBITDA SCHOTT Pharma Q3 2025 FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:53, 9 months 8 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin SCHOTT Pharma AG & Co. KGaA specifies FY 2025 guidance for revenue growth and EBITDA margin, expecting 6.0% organic revenue growth and 28.0% EBITDA margin Revenue Growth EBITDA Margin SCHOTT Pharma Guidance FY 2025
BRIEF published on 06/11/2025 at 08:55, 11 months 2 days ago SCHOTT Pharma prolonge le contrat de son PDG et nomme un nouveau directeur financier Expansion Mondiale Prolongation Du Contrat Du PDG Nomination D'un Nouveau Directeur Financier Confinement Pharmaceutique Leadership Innovant
BRIEF published on 06/11/2025 at 08:55, 11 months 2 days ago SCHOTT Pharma Extends CEO Contract and Appoints New CFO Global Expansion CEO Contract Extension Innovative Leadership New CFO Appointment Pharmaceutical Containment
PRESS RELEASE published on 06/11/2025 at 08:50, 11 months 2 days ago SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO SCHOTT Pharma extends CEO's contract Andreas Reisse & appoints Reinhard Mayer as CFO. Strategic personnel changes at SCHOTT Pharma AG & Co. KGaA CFO Appointment SCHOTT Pharma Personnel Changes CEO Contract Reinhard Mayer
BRIEF published on 06/04/2025 at 15:35, 11 months 9 days ago SCHOTT Pharma étend sa production de cartouches stériles en Hongrie Expansion SCHOTT Pharma Pharmaceutique Hongrie Cartouches Stériles
BRIEF published on 06/04/2025 at 15:35, 11 months 9 days ago SCHOTT Pharma Expands Sterile Cartridge Production in Hungary Expansion Pharmaceutical SCHOTT Pharma Hungary Sterile Cartridges
PRESS RELEASE published on 06/04/2025 at 15:30, 11 months 9 days ago SCHOTT Pharma invests in sterile cartridge production in Hungary SCHOTT Pharma invests over EUR 100 million in new sterile cartridge production facility in Hungary to meet market demand for high-value solutions Expansion Investment SCHOTT Pharma Hungary Sterile Cartridge Production
BRIEF published on 05/15/2025 at 07:05, 11 months 29 days ago SCHOTT Pharma annonce de solides performances au deuxième trimestre 2025 SCHOTT Pharma Croissance Des Revenus Des Solutions À Forte Valeur Ajoutée Résultats Du Deuxième Trimestre 2025 Innovations Pharmaceutiques
Published on 05/13/2026 at 23:05, 21 minutes ago Vox Royalty Reports Record Q1 2026 Results, Increases 2026 Guidance and Declares Quarterly Dividend
Published on 05/13/2026 at 22:30, 56 minutes ago Amdocs Entitlement Server Sets New Industry Performance Benchmark on Microsoft Azure
Published on 05/13/2026 at 22:25, 1 hour 1 minute ago Lumen Technologies Accelerates Cloud-First Strategy with Amdocs, Expands Migration of Enterprise Billing Platform to Microsoft Azure
Published on 05/13/2026 at 22:25, 1 hour 1 minute ago Worksport (NASDAQ:WKSP) Reports Q1 Revenue Up 48%, Gross Profit Up 116% (YOY)
Published on 05/13/2026 at 22:20, 1 hour 5 minutes ago Rumble Announces Initial Results of Exchange Offer for Northern Data
Published on 05/13/2026 at 20:18, 3 hours 7 minutes ago EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 19:28, 3 hours 57 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/13/2026 at 19:14, 4 hours 11 minutes ago EQS-Adhoc: Oldenburgische Landesbank AG: Oldenburgische Landesbank AG intends to call its Additional Tier 1 bond
Published on 05/13/2026 at 18:02, 5 hours 23 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 5 hours 26 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 5 hours 41 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
